クリングルファーマ株式会社.

NEWS

お知らせ


Warning: Invalid argument supplied for foreach() in /home/r3716923/public_html/kringle-pharma.com/wp-content/themes/kringle_pharma/view/single/default.php on line 21
2012.05.17

Renal disease Phase Ib completed

In April 2012, Kringle Pharma completed Phase Ib clinical trial of recombinant human HGF in the United States. Primary objectives of the trial, the safety and pharmacokinetics of multiple intravenous dosing of HGF, were successfully evaluated.